The Johns Hopkins Brady Urological Institute is proud to offer the first MRI-guided TULSA (Transurethral Ultrasound Ablation) Program in the Baltimore/Washington, DC region, providing an incision-free treatment option for patients with prostate cancer and benign prostatic hyperplasia (BPH).
The Johns Hopkins Brady Urological Institute is recognized as one of the premier urological centers in the world and home to many of the most accomplished experts in urologic medicine. Our team collaborates closely with specialists in oncology, pediatrics, nephrology, and other disciplines across Johns Hopkins to deliver personalized treatment plans and exceptional, research-driven care.
The Johns Hopkins Hospital and Brady Urological Institute have consistently ranked among the top hospitals and urology programs in the nation by U.S. News & World Report, known for leadership in both clinical care and groundbreaking research in urologic diseases.
Call: 410-657-5490
Director of the Prostate Cancer Active Surveillance Program
Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute.
Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA.
Director of Prostate Cancer Programs
Arvin K. George, MD, is a urologic surgeon specializing in the diagnosis and management of genitourinary cancers, with particular sub-specialization in kidney and prostate cancers. His clinical interests and expertise are in image-guided therapeutics, and minimally-invasive ablative/surgical techniques for prostate and kidney cancer. These include laparoscopic and robotic surgery, in addition to cryoablation, high-intensity focused ultrasound ablation, nanoparticle directed laser ablation, laser interstitial thermal therapy, and bipolar radiofrequency ablation.
Assistant Director ICTR Imaging Translational Program
Dr. Katarzyna J. Macura is a professor in the Johns Hopkins Medicine department of radiology and radiological science, a professor of oncology and urology at the Johns Hopkins University School of Medicine, and a member of the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Precision Medicine Center of Excellence for Prostate Cancer. She is a radiologist consultant for the Prostate Cancer Multidisciplinary Clinic at The Johns Hopkins Hospital in Baltimore, MD. Dr. Macura established a clinical and research prostate imaging program with a focus on magnetic resonance imaging (MRI). Dr. Macura has expertise in cross-sectional body imaging, MRI and prostate cancer, and image-guided biopsies.
Find a Center
Contact Us